|Day Low/High||1.24 / 1.27|
|52 Wk Low/High||0.93 / 2.43|
VANCOUVER, British Columbia, Feb. 14, 2019 /PRNewswire/ -- Premier Health Group (CSE: PHGI) (OTCQB: PHGRF) ( Frankfurt: 6PH) (the "Company" or "Premier Health"), a Company focused on developing innovative approaches that combine human skill-based...
The Texas-based biotech raised just $9 million in an unorthodox IPO earlier this year, but FDA move should slice months off the time it takes to complete phase 2 trials.
These under -$10 stocks are poised to breakout and trade higher from current levels.
Here's the lowdown on the biotech companies that have come public this year.
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) announced that it has completed the acquisition of Metabasis Therapeutics, Inc.
Several small-cap stocks were poised to move on above-average volume during Tuesday's session.
Several small-cap stocks were moving on above-average volume during Thursday's session.
The stock rises on unusual volume as news of an acquisition emerges.
Cortex Pharma climbs on greenlight from the FDA for an Alzheimer's trial.
Shares slump on disappointing results for type 2 diabetes candidate CS-917.
It boasts best-in-class drugs, but its bump from Tamiflu is temporary and its valuation implies risk.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.